Trademark: 86227226
Status Date
Monday, September 7, 2015
Filing Date
Thursday, March 20, 2014
Published for Opposition
Tuesday, August 5, 2014
Abandoned Date
Monday, September 7, 2015
1 Active chemical ingredients for use in the manufacture of pharmaceuticals for treating inflammatory conditions; Bio-metallic compounds for use in the manufacture of pharmaceutical preparations; Chemical additives for use in the manufacture of anti-inflammatory agent; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Excipients for use in the manufacture of anti-inflammatory; Glycerine for use in the manufacture of pharmaceuticals; Glycerol for use in the manufacture of medicine; Phenothiazine for use as a pharmaceutical intermediate; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; the foregoing goods containing N-acetylcysteine
5 Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; the foregoing goods containing N-acetylcysteine
Color is not claimed as a feature of the mark.
Sep 8, 2015
Abandonment Notice Mailed - No Use Statement Filed
Sep 7, 2015
Abandonment - No Use Statement Filed
Feb 3, 2015
Noa E-Mailed - Sou Required From Applicant
Dec 19, 2014
Extension Of Time To Oppose Process - Terminated
Aug 21, 2014
Extension Of Time To Oppose Received
Aug 5, 2014
Official Gazette Publication Confirmation E-Mailed
Aug 5, 2014
Published For Opposition
Jul 16, 2014
Notification Of Notice Of Publication E-Mailed
Jun 30, 2014
Law Office Publication Review Completed
Jun 30, 2014
Assigned To Lie
Jun 12, 2014
Approved For Pub - Principal Register
Jun 12, 2014
Examiner's Amendment Entered
Jun 12, 2014
Notification Of Examiners Amendment E-Mailed
Jun 12, 2014
Examiners Amendment E-Mailed
Jun 12, 2014
Examiners Amendment -Written
Jun 10, 2014
Assigned To Examiner
Apr 3, 2014
New Application Office Supplied Data Entered In Tram
Mar 24, 2014
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
